Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000245852

Medchemexpress LLC Spiro[2H-1-benzopyran-2,4'-[4H]pyran], 2',3',5',6'-tetrahydro-6,7-bis[(4-nitrophenyl)methoxy]- | 2109805-75-4 | MFCD31692328 | 99.0% | 504.49 g/mol | C27H24N2O8 | 1 MG
SDP

Catalog No. 5000245852
Encompass_Preferred

CU-CPT17e is a potent multi-Toll-like receptor (TLR) agonist used in research to activate TLR3, TLR8, and TLR9. It is provided as a high-purity small molecule for in vitro pharmacology and mechanistic studies.

  • Potent multi-TLR agonist activating TLR3, TLR8, and TLR9.
  • High purity (99.0%), suitable for research applications.
  • Molecular weight 504.49 g/mol, formula C27H24N2O8.
  • Soluble in DMSO for standard laboratory assays.
  • Available in multiple pack sizes, including 1 mg screening quantities.
  • Intended for in vitro pharmacology and mechanistic studies.

Catalog No. 50-002-45852 Supplier Medchemexpress LLC Supplier No. HY1019291MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

CU-CPT17e is a potent multi-Toll-like receptor (TLR) agonist used in research to activate TLR3, TLR8, and TLR9. It is provided as a high-purity small molecule for in vitro pharmacology and mechanistic studies.

  • Potent multi-TLR agonist activating TLR3, TLR8, and TLR9.
  • High purity (99.0%), suitable for research applications.
  • Molecular weight 504.49 g/mol, formula C27H24N2O8.
  • Soluble in DMSO for standard laboratory assays.
  • Available in multiple pack sizes, including 1 mg screening quantities.
  • Intended for in vitro pharmacology and mechanistic studies.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.